Why would Venturis Therapeutic's leadership want any of us to discuss the unchallengable fact that Dentons, the company's long-time counsel, quit in April and stated under penalty of perjury to a court that Venturis has no assets of value nor income streams from which to pay $200,000+ in overdue invoices?
This very uncomfortable fact (which can not be challenged) completely invalidates and negates the narrative that Venturis Therapeutic's leadership continues to try to spin. Namely, that Venturis Therapeutics remains viable.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.